Paolo Strati, MD; University of Texas MD Anderson Cancer Center 5Live #ASCO20
5:45
Key insights on Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).
Key insights on Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).
Lymphoma Similar Videos
-
IUCLS 2023 Saturday Afternoon General Session_Sonali Smith, MD, FASCO_Andrew Evens, DO, MBA, MSc_Timothy Fenske, MD, MS
3:34
-
Virtual Challenging Case Clinic: B-cell Lymphomas - Chronic Lymphocytic Leukemia_Jennifer Brown, MD, PhD
49:09
-
IUCLS 2023 Friday Interprofessional Session_Sonali Smith, MD, FASCO_Andrew Evens, DO, MBA, MSc_Timothy Fenske, MD, MS
10:30